Q32 Bio Inc (QTTB) — Cash Flow-to-Debt Ratio
Q32 Bio Inc (QTTB) has a Cash Flow-to-Debt Ratio of -0.37x as of March 2026, meaning its operating cash flow of $-6.34 Million could theoretically repay 0% of its total liabilities ($17.36 Million) in one year. Explore how much of Q32 Bio Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Q32 Bio Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Q32 Bio Inc across 10 annual periods. Also explore total assets of Q32 Bio Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Q32 Bio Inc (2016–2025)
Year-by-year debt coverage analysis for Q32 Bio Inc. For market capitalisation and broader financial context, see QTTB market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.70x | $-33.54 Million | $19.76 Million | ▼ -117.2% |
| 2024 | -0.78x | $-67.72 Million | $86.66 Million | ▼ -862.2% |
| 2023 | -0.08x | $-18.68 Million | $229.98 Million | ▼ -42.7% |
| 2022 | -0.06x | $-10.96 Million | $192.49 Million | ▲ +97.8% |
| 2021 | -2.61x | $-109.75 Million | $42.07 Million | ▼ -87.3% |
| 2020 | -1.39x | $-94.33 Million | $67.74 Million | ▲ +20.6% |
| 2019 | -1.75x | $-91.36 Million | $52.06 Million | ▼ -158.7% |
| 2018 | -0.68x | $-42.56 Million | $62.74 Million | ▼ -510.7% |
| 2017 | 0.17x | $6.48 Million | $39.22 Million | ▲ +113.1% |
| 2016 | -1.26x | $-8.48 Million | $6.72 Million | — |